Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan F Leitman

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Blood|July 18, 2009
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell doseMichael A Pulsipher, Pintip Chitphakdithai, Brent R Logan, et al.
Bone Marrow Transplantation|May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myelomaNishant Tageja, Neha Korde, Dickran Kazandjian, et al.
Blood|January 10, 2002
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndromeElizabeth M Kang, Moniek de Witte, Harry Malech, et al.
Transfusion|October 12, 2002
Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donationCharles D Bolan, Stacey A Cecco, Robert A Wesley, et al.
Medical and Pediatric Oncology|February 12, 2002
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH studyRamzi Dagher, Lauren M Long, Elizabeth J Read, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201Galen E Switzer, Jessica G Bruce, Donna Harrington, et al.
The American Journal of Cardiology|September 20, 2011
Changes in left ventricular diastolic function of asymptomatic hereditary hemochromatosis subjects during five years of follow-upYukitaka Shizukuda, Dorothy J Tripodi, Vandana Sachdev, et al.
The American Journal of Cardiology|August 23, 2006
Left ventricular systolic function during stress echocardiography exercise in subjects with asymptomatic hereditary hemochromatosisYukitaka Shizukuda, Charles D Bolan, Dorothy J Tripodi, et al.
Transfusion|February 14, 2004
Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimensCharles D Bolan, Yu Ying Yau, Herbert C Cullis, et al.
Transfusion|September 3, 2011
Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donorsMatthew J Olnes, Andrea Poon, Susan J Miranda, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Blood|July 18, 2009
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell doseMichael A Pulsipher, Pintip Chitphakdithai, Brent R Logan, et al.
Bone Marrow Transplantation|May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myelomaNishant Tageja, Neha Korde, Dickran Kazandjian, et al.
Blood|January 10, 2002
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndromeElizabeth M Kang, Moniek de Witte, Harry Malech, et al.
Transfusion|October 12, 2002
Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donationCharles D Bolan, Stacey A Cecco, Robert A Wesley, et al.
Medical and Pediatric Oncology|February 12, 2002
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH studyRamzi Dagher, Lauren M Long, Elizabeth J Read, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201Galen E Switzer, Jessica G Bruce, Donna Harrington, et al.
The American Journal of Cardiology|September 20, 2011
Changes in left ventricular diastolic function of asymptomatic hereditary hemochromatosis subjects during five years of follow-upYukitaka Shizukuda, Dorothy J Tripodi, Vandana Sachdev, et al.
The American Journal of Cardiology|August 23, 2006
Left ventricular systolic function during stress echocardiography exercise in subjects with asymptomatic hereditary hemochromatosisYukitaka Shizukuda, Charles D Bolan, Dorothy J Tripodi, et al.
Transfusion|February 14, 2004
Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimensCharles D Bolan, Yu Ying Yau, Herbert C Cullis, et al.
Transfusion|September 3, 2011
Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donorsMatthew J Olnes, Andrea Poon, Susan J Miranda, et al.
Pageof 11